Giró Perafita, Ariadna (Date of defense: 2017-01-17)
Triple-negative breast cancer (TNBC) represents 20% of breast cancer and patients receive only general chemotherapy. The epidermal growth factor receptor (EGFR) is commonly expressed in TNBC and it is ...
Rabionet Diaz, Marc (Date of defense: 2021-11-08)
Triple negative breast cancer (TNBC) accounts for 15-20% of the breast cancers and displays an aggressive profile, poor prognosis, high relapse risk and does not have a targeted therapy. In the last ...
Carbó Bagué, Anna (Date of defense: 2023-03-27)
In this doctoral thesis, the epidemiology of cutaneous and mucosal melanoma is analyzed, as well as its molecular profile to provide new knowledge on a population basis in the province of Girona. The ...
Polonio Alcalá, Emma (Date of defense: 2023-05-17)
Although there are therapies for triple negative breast cancer (TNBC) and epidermal growth factor-mutated non-small cell lung cancer (EGFRm NSCLC), these two subtypes of cancer are very aggressive, and ...
Perruca Martínez, Cristina (Date of defense: 2022-03-04)
The lack of knowledge and skills in the care of infants in their first years of life often results in frequent paediatric consultations for banal problems and doubts, which are often a result of a low ...